Sienna Biopharmaceuticals (Silver Photoparticle Technology Assets) is Buildings and Property in United States that focus on Silver photoparticle technology assets business. They cover business area such as silver photoparticle technology asset, Westlake Village, California.
-
Silver Photoparticle Technology Assets
-
30699 Russell Ranch Road
Suite 140
Westlake Village, CA 91362
United States
Private
silver photoparticle technology assetWestlake VillageCalifornia
* We use standard office opening hours in near Sienna Biopharmaceuticals (Silver Photoparticle Technology Assets)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Sienna Biopharmaceuticals (Silver Photoparticle Technology Assets) is Buildings and Property business from United States that founded in - ( years old in ), Sienna Biopharmaceuticals (Silver Photoparticle Technology Assets) business is focusing on Silver Photoparticle Technology Assets.
Sienna Biopharmaceuticals (Silver Photoparticle Technology Assets) headquarter office and corporate office address is located in 30699 Russell Ranch Road Suite 140 Westlake Village, CA 91362 United States.
Sienna Biopharmaceuticals (Silver Photoparticle Technology Assets) was founded in United States.
In , Sienna Biopharmaceuticals (Silver Photoparticle Technology Assets) is currently focus on Silver photoparticle technology assets sector.
Above is snippet of Google Trends for "Silver photoparticle technology assets" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Sienna Biopharmaceuticals (Silver Photoparticle Technology Assets), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
